التفاصيل البيبلوغرافية
| العنوان: |
Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels. |
| المؤلفون: |
Bersani, Iliana, Ferrari, Fabrizio, Lugli, Licia, Ivani, Giorgio, Conio, Alessandra, Moataza, Bashir, Aboulgar, Hanna, Mufeed, Hala, Iskander, Iman, Kornacka, Maria, Gruzfeld, Darek, Dotta, Andrea, Savarese, Immacolata, Chukhlantseva, Natalia, Tina, Lucia Gabriella, Nigro, Francesco, Livolti, Giovanni, Galvano, Fabio, Serpero, Laura, Colivicchi, Micaela |
| المصدر: |
Clinical Chemistry & Laboratory Medicine; Jul2019, Vol. 57 Issue 7, p1017-1025, 9p, 1 Diagram, 2 Charts, 4 Graphs |
| مصطلحات موضوعية: |
HYPOTHERMIA treatment, ASPHYXIA neonatorum, NEWBORN infants, BIOLOGICAL tags, CRITICAL care medicine |
| مستخلص: |
Background: Perinatal asphyxia is a major cause of mortality and morbidity in neonates: The aim of the present study was to investigate, by means of longitudinal assessment of urinary S100B, the effectiveness of hypothermia, in infants complicated by perinatal asphyxia and hypoxic-ischemic encephalopathy. Methods: We performed a retrospective case-control study in 108 asphyxiated infants, admitted to nine tertiary departments for neonatal intensive care from January 2004 to July 2017, of whom 54 underwent hypothermia treatment and 54 did not. The concentrations of S100B protein in urine were measured using an immunoluminometric assay at first urination and 4, 8, 12, 16, 20, 24, 48, 72, 96, 108 and 120 h after birth. The results were correlated with the achievement of S100B levels within normal ranges at 72 h from hypothermia treatment. Routine laboratory parameters, longitudinal cerebral function monitoring, cerebral ultrasound and neurologic patterns were assessed according to standard protocols. Results: Higher S100B concentrations were found in hypothermia-treated infants in both moderate (up to 12 h) and severe (up to 24 h) hypoxic-ischemic encephalopathy. S100B levels returned to normal ranges starting from 20 h of hypothermia treatment in moderate and from 36 h in severe hypoxic-ischemic encephalopathy. Conclusions: The present results offer additional support to the usefulness of longitudinal neuro-biomarkers monitoring in asphyxiated infants treated by hypothermia. The pattern of S100B concentrations during hypothermia supports the need for further investigations aimed at reconsidering the time-window for patient recruitment and treatment, and the optimal duration of the cooling and rewarming phases of the hypothermia procedure. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Chemistry & Laboratory Medicine is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
